Abstract
The study of the mechanism of β-N-methylamino-l-alanine (BMAA) neurotoxicity originally focused on its effects at the N-methyl-d-aspartate (NMDA) receptor. In recent years, it has become clear that its mechanism of action is more complicated. First, there are certain cell types, such as motor neurons and cholinergic neurons, where the dominate mechanism of toxicity is through action at AMPA receptors. Second, even in cortical neurons where the primary mechanism of toxicity appears to be activation of NMDA receptors, there are other mechanisms involved. We found that along with NMDA receptors, activation of mGLuR5 receptors and effects on the cystine/glutamate antiporter (system xc-) were involved in the toxicity. The effects on system xc- are of particular interest. System xc- mediates the transport of cystine into the cell in exchange for releasing glutamate into the extracellular fluid. By releasing glutamate, system xc- can potentially cause excitotoxicity. However, through providing cystine to the cell, it regulates the levels of cellular glutathione (GSH), the main endogenous intracellular antioxidant, and in this way may protect cells against oxidative stress. We have previously published that BMAA inhibits cystine uptake leading to GSH depletion and had indirect evidence that BMAA is transported into the cells by system xc-. We now present direct evidence that BMAA is transported into both astrocytes and neurons through system xc-. The fact that BMAA is transported by system xc- also provides a mechanism for BMAA to enter brain cells potentially leading to misincorporation into proteins and protein misfolding.
Similar content being viewed by others
References
Albano R, Liu X, Lobner D (2013) Regulation of system xc- in the SOD1-G93A mouse model of ALS. Exp Neurol 250:69–73. doi:10.1016/j.expneurol.2013.09.008
Bannai S (1986) Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem 261:2256–2263
Bannai S, Kitamura E (1980) Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture. J Biol Chem 255:2372–2376
Carriedo SG, Yin HZ, Lamberta R, Weiss JH (1995) In vitro kainate injury to large, SMI-32(+) spinal neurons is Ca2+ dependent. Neuroreport 6:945–948
Choi DW, Maulucci-Gedde M, Kriegstein AR (1987) Glutamate neurotoxicity in cortical cell culture. J Neurosci 7:357–368
Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689–695
Doble A (1999) The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 81:163–221
Domercq M, Sanchez-Gomez MV, Sherwin C, Etxebarria E, Fern R, Matute C (2007) System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J Immunol 178:6549–6556. doi:10.4049/jimmunol.178.10.6549
Dugan LL, Bruno VMG, Amagasu SM, Giffard RG (1995) Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. J Neurosci 15:4545–4555
Dunlop RA, Cox PA, Banack SA, Rodgers KJ (2013) The non-protein amino acid BMAA is misincorporated into human proteins in place of L-serine causing protein misfolding and aggregation. PLoS One 8:e75376. doi:10.1371/journal.pone.0075376
Fogal B, Li J, Lobner D, McCullough LD, Hewett SJ (2007) System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury. J Neurosci 27:10094–10105
Glover WB, Mash DC, Murch SJ (2014) The natural non-protein amino acid N-b-methylamino-L-alanine (BMAA) is incorporated into protein during synthesis. Amino Acids 46:2553–2559. doi:10.1007/s00726-014-1812-1
He Y, Jackman NA, Thorn TL, Vought VE, Hewett SJ (2015) Interleukin-1β protects astrocytes against oxidant-induced injury via an NF-κB-dependent upregulation of glutathione synthesis. Glia 63:1568–1580. doi:10.1002/glia.22828
Jackman NA, Uliasz TF, Hewett JA, Hewett SJ (2010) Regulation of system x(c)(−) activity and expression in astrocytes by interleukin-1β: implications for hypoxic neuronal injury. Glia 58:1806–1815. doi:10.1002/glia.21050
Karlsson O, Lindquist NG, Brittebo EB, Roman E (2009) Selective brain uptake and behavioral effects of the cyanobacterial toxin BMAA (beta-N-methylamino-L-alanine) following neonatal administration to rodents. Toxicol Sci 109:286–295. doi:10.1093/toxsci/kfp062
Liu X, Rush T, Zapata J, Lobner D (2009) Beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system xc(−). Exp Neurol 217:429–433. doi:10.1016/j.expneurol.2009.04.002
Liu XQ, Rush T, Ciske J, Lobner D (2010) Selective death of cholinergic neurons induced by beta-methylamino-L-alanine. Neuroreport 21:55–58. doi:10.1097/WNR.0b013e328333dfd5
Lobner D (2000) Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis? J Neurosci Methods 96:147–152
Lobner D, Piana PM, Salous AK, Peoples RW (2007) Beta-N-methylamino-L-alanine enhances neurotoxicity through multiple mechanisms. Neurobiol Dis 25:360–366. doi:10.1016/j.nbd.2006.10.002
Massie A, Schallier A, Mertens B et al (2008) Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats. Neuroreport 19:1589–1592. doi:10.1097/WNR.0b013e328312181c
Massie A, Schallier A, Kim SW et al (2011) Dopaminergic neurons of system x(c)−-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity. FASEB J 25:1359–1369. doi:10.1096/fj.10-177212
Mesci P, Zaïdi S, Lobsiger CS et al (2015) System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice. Brain 138:53–68. doi:10.1093/brain/awu312
Miyamoto M, Murphy TH, Schnaar RL, Coyle JT (1989) Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J Pharmacol Exp Ther 250:1132–1140
Miyazaki I, Murakami S, Torigoe N, Kitamura Y, Asanuma M (2016) Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice. J Neurochem 136:194–204. doi:10.1111/jnc.13405
Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2:1547–1558
Murphy TH, Schnaar RL, Coyle JT (1990) Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J 4:1624–1633
Pauly K, Fritz K, Furey A, Lobner D (2011) Insulin-like growth factor 1 and transforming growth factor-β stimulate cystine/glutamate exchange activity in dental pulp cells. J Endod 37:943–947. doi:10.1016/j.joen.2011.03.031
Piani D, Fontana A (1994) Involvement of the cystine transport system xc- in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J Immunol 152:3578–3585
Qin S, Colin C, Hinners I, Gervais A, Cheret C, Mallat M (2006) System xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40. J Neurosci 26:3345–3356. doi:10.1523/JNEUROSCI.5186-05.2006
Rao SD, Banack SA, Cox PA, Weiss JH (2006) BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Exp Neurol 201:244–252. doi:10.1016/j.expneurol.2006.04.017
Ratan RR, Murphy TH, Baraban JM (1994) Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione. J Neurosci 14:4385–4392
Ross SM, Seelig M, Spencer PS (1987) Specific antagonism of excitotoxic action of ‘uncommon’ amino acids assayed in organotypic mouse cortical cultures. Brain Res 425:120–127
Rush T, Liu XQ, Hjelmhaug J, Lobner D (2010) Mechanisms of chlorpyrifos and diazinon induced neurotoxicity in cortical culture. Neuroscience 166:899–906. doi:10.1016/j.neuroscience.2010.01.025
Sagara JI, Miura K, Bannai S (1993) Maintenance of neuronal glutathione by glial cells. J Neurochem 61:1672–1676
Schallier A, Smolders I, Van Dam D et al (2011) Region- and age-specific changes in glutamate transport in the AβPP23 mouse model for Alzheimer’s disease. J Alzheimers Dis 24:287–300. doi:10.3233/JAD-2011-101005
Schwartz JP, Wilson DJ (1992) Preparation and characterization of type 1 astrocytes cultured from adult rat cortex, cerebellum, and striatum. Glia 5:75–80
Simonian NA, Coyle JT (1996) Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36:83–106
Smith QR, Nagura H, Takada Y, Duncan MW (1992) Facilitated transport of the neurotoxin, beta-N-methylamino-L-alanine, across the blood-brain barrier. J Neurochem 58:1330–1337
Weiss JH, Koh JY, Choi DW (1989) Neurotoxicity of beta-N-methylamino-L-alanine (BMAA) and beta-N-oxalylamino-L-alanine (BOAA) on cultured cortical neurons. Brain Res 497:64–71
Yin HZ, Turetsky D, Choi DW, Weiss JH (1994) Cortical neurones with Ca2+ permeable AMPA/kainate channels display distinct receptor immunoreactivity and are GABAergic. Neurobiol Dis 1:43–49
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with ethical standards of the institution or practice at which the studies were conducted.
Rights and permissions
About this article
Cite this article
Albano, R., Lobner, D. Transport of BMAA into Neurons and Astrocytes by System xc-. Neurotox Res 33, 1–5 (2018). https://doi.org/10.1007/s12640-017-9739-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-017-9739-4